Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Governments worldwide are facing the challenge of introducing artificial intelligence (AI) ...
The European Commission has published an updated Questions and Answers document concerning the Clinical Trials Regulation (EU) 536/2014. The document provides clarification regarding the ...
Artificial Intelligence (AI) can augment productivity in clinical trial delivery and more, says Piotr Maslak, Director of Operational Data Intelligence at AstraZeneca. Maslak was speaking on the first ...
Background: Clinical trials do not represent community settings,making widespread implementation of evidence-based medicineproblematic. New heart failure treatments are an example, asresults ...
Integrating Patient-Reported Outcomes Into Cancer Symptom Management Clinical Trials Supported by the National Cancer Institute–Sponsored Clinical Trials Networks The purpose of this article is to ...
Aptiv Solutions Announces the Launch of AptivAdvantageTM– A Unique Integrated Technology Platform for the Implementation and Execution of Adaptive Clinical Trials RESTON, Va.--(BUSINESS WIRE)--Aptiv ...
This article presents an example of how clinical trial data may be complemented by real-world evidence by reviewing pivotal clinical trial data for one direct oral anticoagulant (DOAC), along with an ...
Despite efforts to enhance enrollment and the merger of national cooperative groups, < 5% of patients with cancer will enroll into a clinical trial. Additionally, clinical trials are affected by a ...
Recently, China's National Medical Products Administration (“NMPA”) released a new version of the Inspection Points for Clinical Trials of Medical Devices. This new rule replaces two previous versions ...
Through this deepened collaboration, CTI is accredited in Medidata eCOA to further improve data collection capabilities, enhancing the clinical trial experience for patients by enabling the collection ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results